|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
*See the Appendix on page 535 for a listing of the members of the Tourettes Syndrome Study Group.
Address correspondence and reprint requests to Dr. Roger Kurlan, Department of Neurology, University of Rochester Medical Center, Rochester, NY 146428673; e-mail: Kurlan{at}neuron.mct.rochester.edu
Background: The treatment of children with attention deficit hyperactivity disorder (ADHD) and Tourette syndrome (TS) has been problematic because methylphenidate (MPH)the most commonly used drug to treat ADHDhas been reported to worsen tics and because clonidine (CLON)the most commonly prescribed alternativehas unproven efficacy.
Methods: The authors conducted a multicenter, randomized, double-blind clinical trial in which 136 children with ADHD and a chronic tic disorder were randomly administered CLON alone, MPH alone, combined CLON + MPH, or placebo (2 x 2 factorial design). Each subject participated for 16 weeks (weeks 14 CLON/placebo dose titration, weeks 58 added MPH/placebo dose titration, weeks 916 maintenance therapy).
Results: Thirty-seven children were administered MPH alone, 34 were administered CLON alone, 33 were administered CLON + MPH, and 32 were administered placebo. For our primary outcome measure of ADHD (Conners Abbreviated Symptom QuestionnaireTeacher), significant improvement occurred for subjects assigned to CLON (p < 0.002) and those assigned to MPH (p < 0.003). Compared with placebo, the greatest benefit occurred with combined CLON + MPH (p < 0.0001). CLON appeared to be most helpful for impulsivity and hyperactivity; MPH appeared to be most helpful for inattention. The proportion of individual subjects reporting a worsening of tics as an adverse effect was no higher in those treated with MPH (20%) than those being administered CLON alone (26%) or placebo (22%). Compared with placebo, measured tic severity lessened in all active treatment groups in the following order: CLON + MPH, CLON alone, MPH alone. Sedation was common with CLON treatment (28% reported moderate or severe sedation), but otherwise the drugs were tolerated well, including absence of any evident cardiac toxicity.
Conclusions: Methylphenidate and clonidine (particularly in combination) are effective for ADHD in children with comorbid tics. Prior recommendations to avoid methylphenidate in these children because of concerns of worsening tics are unsupported by this trial.
This article has been cited by other articles:
![]() |
T. J. Spencer, F. R. Sallee, D. L. Gilbert, D. W. Dunn, J. T. McCracken, B. J. Coffey, C. L. Budman, R. K. Ricardi, H. L. Leonard, A. J. Allen, et al. Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome J Atten Disord, January 1, 2008; 11(4): 470 - 481. [Abstract] [PDF] |
||||
![]() |
J. G. Wood, J. L. Crager, C. M. Delap, and K. D. Heiskell Literature Review: Beyond Methylphenidate: Nonstimulant Medications for Youth With ADHD J Atten Disord, November 1, 2007; 11(3): 341 - 350. [Abstract] [PDF] |
||||
![]() |
References PsychiatryOnline CME, May 1, 2007; 2007(1): 2 - 2. [Full Text] |
||||
![]() |
B. H. Levine and R. C. Albucher Patient Management Exercise FOR PSYCHOPHARMACOLOGY Focus, September 1, 2006; 4(4): 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gaze, H. O. Kepley, and J. T. Walkup Co-occurring Psychiatric Disorders in Children and Adolescents With Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 657 - 664. [Abstract] [PDF] |
||||
![]() |
D. Gilbert Treatment of Children and Adolescents With Tics and Tourette Syndrome J Child Neurol, August 1, 2006; 21(8): 690 - 700. [Abstract] [PDF] |
||||
![]() |
D. L. Gilbert, Z. Wang, F. R. Sallee, K. R. Ridel, S. Merhar, J. Zhang, T. D. Lipps, C. White, N. Badreldin, and E. M. Wassermann Dopamine transporter genotype influences the physiological response to medication in ADHD Brain, August 1, 2006; 129(8): 2038 - 2046. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Gilbert and C. R. Buncher Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette's Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses J Neuropsychiatry Clin Neurosci, August 1, 2005; 17(3): 324 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Wolraich, C. J. Wibbelsman, T. E. Brown, S. W. Evans, E. M. Gotlieb, J. R. Knight, E. C. Ross, H. H. Shubiner, E. H. Wender, and T. Wilens Attention-Deficit/Hyperactivity Disorder Among Adolescents: A Review of the Diagnosis, Treatment, and Clinical Implications Pediatrics, June 1, 2005; 115(6): 1734 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
C R Steer Managing attention deficit/hyperactivity disorder: unmet needs and future directions Arch. Dis. Child., February 1, 2005; 90(suppl_1): i19 - i25. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Rappley Attention Deficit-Hyperactivity Disorder N. Engl. J. Med., January 13, 2005; 352(2): 165 - 173. [Full Text] [PDF] |
||||
![]() |
J S Stern, S Burza, and M M Robertson Gilles de la Tourette's syndrome and its impact in the UK Postgrad. Med. J., January 1, 2005; 81(951): 12 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Becker, M. Holtmann, M. El-Faddagh, and M. H. Schmidt Separation Anxiety Triggered by Atypical Neuroleptic Medication in an Adolescent with Tourette's Syndrome Clinical Child Psychology and Psychiatry, October 1, 2004; 9(4): 597 - 603. [Abstract] [PDF] |
||||
![]() |
A. M. Kanner and D. W. Dunn Diagnosis and Management of Depression and Psychosis in Children and Adolescents With Epilepsy J Child Neurol, August 1, 2004; 19(1_suppl): S65 - S72. [Abstract] [PDF] |
||||
![]() |
V. Bhatara, M. Feil, K. Hoagwood, B. Vitiello, and B. Zima National trends in concomitant psychotropic medication with stimulants in pediatric visits: Practice versus knowledge J Atten Disord, May 1, 2004; 7(4): 217 - 226. [Abstract] [PDF] |
||||
![]() |
D. J. Safer, J. M. Zito, and S. dosReis Concomitant Psychotropic Medication for Youths Am J Psychiatry, March 1, 2003; 160(3): 438 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Gilbert, L. Dure, G. Sethuraman, D. Raab, J. Lane, and F. R. Sallee Tic reduction with pergolide in a randomized controlled trial in children Neurology, February 25, 2003; 60(4): 606 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Efron, H. Hiscock, J. R. Sewell, N. E. Cranswick, A. L. A. Vance, Y. Tyl, and E. S. L. Luk Prescribing of Psychotropic Medications for Children by Australian Pediatricians and Child Psychiatrists Pediatrics, February 1, 2003; 111(2): 372 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Schlaggar and J. W. Mink Movement Disorders in Children Pediatr. Rev., February 1, 2003; 24(2): 39 - 51. [Full Text] [PDF] |
||||
![]() |
OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02) Evid. Based Nurs., January 1, 2003; 6(1): e1 - 1. [Full Text] [PDF] |
||||
![]() |
J Goldberg Clonidine and methylphenidate were effective for attention deficit hyperactivity disorder in children with comorbid tics Evid. Based Med., September 1, 2002; 7(5): 157 - 157. [Full Text] [PDF] |
||||
![]() |
Clonidine Plus Methylphenidate for ADHD and Tics in Children Journal Watch Neurology, June 27, 2002; 2002(627): 5 - 5. [Full Text] |
||||
![]() |
Treatment of Children with ADHD and Tic Disorders Journal Watch Pediatrics and Adolescent Medicine, June 10, 2002; 2002(610): 11 - 11. [Full Text] |
||||
![]() |
J. G. Millichap Efficacy and Safety of Methylphenidate for ADHD with Tics AAP Grand Rounds, May 1, 2002; 7(5): 49 - 50. [Full Text] [PDF] |
||||
![]() |
C. G. Goetz and V. K. Hinson Therapies for Movement Disorders Arch Neurol, May 1, 2002; 59(5): 699 - 702. [Full Text] [PDF] |
||||
![]() |
Effective Treatments for Comorbid Tics and ADHD? Journal Watch Psychiatry, April 10, 2002; 2002(410): 7 - 7. [Full Text] |
||||
![]() |
R. Nass and S. Bressman Attention deficit hyperactivity disorder and Tourette syndrome: What's the best treatment? Neurology, February 26, 2002; 58(4): 513 - 514. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |